Ecnoglutide Phase 3 trial (NCT05680129)
A Phase 3, Multi-center, Open-label, Randomized Study to Evaluate the Efficacy and Safety of XW003 Versus Dulaglutide in Patients With T2DM Inadequately Controlled by Metformin
Registry record checked
At a glance
- Phase
- Phase 3
- Status
- Completed
- Enrolment
- 623
- actual
- Start
- 10 Jan 2023 (actual)
- Primary completion
- 3 Jul 2024 (actual)
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
Design
Arms and doses
| Arm | Type | Interventions | Description |
|---|---|---|---|
| B1: XW003+MET | Experimental | Drug: Ecnoglutide high dosage; Drug: Metformin | High dosage of XW003 once weekly |
| B2: XW003+MET | Experimental | Drug: Ecnoglutide low dosage; Drug: Metformin | Low dosage of XW003 once weekly |
| B3: Dulaglutide+MET | Active comparator | Drug: Dulaglutide; Drug: Metformin | 1.5mg Dulaglutide once weekly |
Endpoints
Primary endpoint
| Measure | Time frame |
|---|---|
| Change from baseline in HbA1c | Baseline, week 32 |
Endpoints
Key secondary endpoints
The first secondary outcomes listed on the registry record.
| Measure | Time frame |
|---|---|
| Change from baseline in HbA1c | Baseline, Week 5, Week 9, Week 13, Week 17, Week 25, Week 43 and Week 52 |
| Change from baseline in fasting plasma glucose (FPG) | Baseline, Week 32 and Week 52 |
| Change from baseline in lipid panel | Baseline, Week 32 and Week 52 |
| Change from baseline in body weight | Baseline, Week 32 and Week 52 |
| Pharmacokinetics: plasma trough level of XW003 | Baseline, Day 29, Day 57, Day 85, Day 224, Day 364 and Day 399 |
Eligibility
Who could enrol
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Results
Results
No results posted on ClinicalTrials.gov as of 2 Oct 2026.
Sources
- 1A Phase 3, Multi-center, Open-label, Randomized Study to Evaluate the Efficacy and Safety of XW003 Versus Dulaglutide in Patients With T2DM Inadequately Controlled by MetforminClinicalTrials.gov (U.S. National Library of Medicine) · registry recordclinicaltrials.govAccessed 2 Oct 2026
Found an error? Report a correction.